Proving the Business Case for the Internet of Things

Lamprey gateway allows secure patient monitoring

Steve Rogerson
October 26, 2016
Lamprey Networks has launched its second-generation personal health gateway for secure, standardised and cost-effective monitoring of health populations.
The Health@Home PHG2000L is said to be the first multi-user hub on the market. It is the latest component of Lamprey’s end-to-end interoperability system for remote monitoring, and can be used as part of the New Hampshire company’s turn-key Health@Home offering, purchased off-the-shelf, or customised in bulk via its white label engineering services.
The PHG2000L complies with the Continua design guidelines both in collecting data from devices and in transmitting those data to cloud services. The guidelines are a publicly available framework for authentic, user friendly interoperability of personal connected health devices, and adopted by the ITU as standard H.810. The PHG2000L is designed for connectivity via Ethernet, wifi or cellular.
“The PHG2000L achieves a significant step forward for remote monitoring in healthcare by addressing clinical concerns related to patient identity, correctness of time and measurement representation while providing the simplest possible user experience in a cost effective platform that supports enterprise management, provisioning and security,” said Barry Reinhold, president and CTO of Lamprey. “Further, the PHG2000L is unique in that the personal health information can be separated from other device communications, allowing it to address a wide range of privacy issues.”
Health@Home comprises hardware and software hubs, devices, analytics and services for remote monitoring in healthcare and life sciences. It provides customer site components such as sensors and hubs and helps users manage deployed equipment and collect device observations from a single IP address. Health@Home Spectrum offers a complete product and service package that includes data analytics application. SDKs are available on multiple platforms to support Continua-compliant device specialisations, data collection and cloud delivery.
“In addition to superior technological features, the PHG2000L provides dramatic economies of scale for healthcare and life sciences buyers, such as those in long term care and rehab facilities, hospitals and clinics managing diabetes or other chronic populations, remote physician visit services, as well as pharmaceutical companies and clinical research organisations deploying monitoring devices in clinical trials,” said Mike Mazzola, CEO of Lamprey. “Further, our white label service provides a branded option for organisations marketing an integrated remote monitoring service.”